Search

Hauser, RA, and TA Zesiewicz. 2007. “Advances in the Pharmacologic Management of Early Parkinson’s Disease.”. Neurologist.

Seeberger, LC, and RA Hauser. 2009. “Levodopa/Carbidopa/Entacapone in Parkinson’s Disease. Expert Rev Neurother”. Expert Rev Neurother.

Jahan, I, RA Hauser, KL Sullivan, A Miller, and TA Zesiewicz. 2009. “Sleep Disorders in Parkinson’s Disease.”. Neuropsychiatr Dis Treat.

Cobb, SA, C Wider, OA Ross, IF Mata, CH Adler, A Rajput, AH Rajput, et al. 2009. “GCH1 in Early-Onset Parkinson’s Disease.”. Mov Disord.

Jenner, P, A Mori, RA Hauser, M Morelli, BB Fredholm, and JF Chen. 2009. “Adenosine, Adenosine A2A Antagonists, and Parkinson’s Disease.”. Parkinsonism Relat Disord.

Kordower, JH, Y Chu, RA Hauser, TB Freeman, and CW Olanow. 2008. “Lewy Body-Like Pathology in Long-Term Embryonic Nigral Transplants in Parkinson’s Disease”. Nat Med.

Truong, D, DD Duane, J Jankovic, C Singer, LC Seeberger, CL Comella, MF Lew, et al. 2005. “Efficacy and Safety of Botulinum Type A Toxin (Dysport) in Cervical Dystonia: Results of the First US Randomized, Double-Blind, Placebo-Controlled Study. Movement Disorders 2005;20:783-791.”. Movement Disorders.

Group, Parkinson Study. 2004. “A Controlled, Randomized, Delayed-Start Study of Rasagiline in Early Parkinson Disease. Arch Neurol 2004;61:561-566.”. Arch Neurol.

Zesiewicz, TA, JA Strom, AR Borenstein, RA Hauser, CR Cimino, H Fontanet, C Cintron, JF Staffetti, PB Dunne, and KL Sullivan. 2004. “Heart Failure in Parkinson’s Disease: Analysis of the United States Medicare Current Beneficiary Survey. Parkinsonism Relat Disord 2004;10:417-420.”. Parkinsonism Relat Disord.

Zesiewicz, TA, W Stamey, KL Sullivan, and RA Hauser. 2004. “Botulinum Toxin A for the Treatment of Cervical Dystonia. Expert Opin Pharmacother 2004;5:2017-2024.”. Expert Opin Pharmcother.